Correction: Cytokine Receptor-Like Factor 1 () Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway.

Bibliographic Details
Main Authors: Brendan D. Looyenga, James Resau, Jeffrey P. MacKeigan
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3882296
_version_ 1818009309458464768
author Brendan D. Looyenga
James Resau
Jeffrey P. MacKeigan
author_facet Brendan D. Looyenga
James Resau
Jeffrey P. MacKeigan
author_sort Brendan D. Looyenga
collection DOAJ
first_indexed 2024-04-14T05:41:23Z
format Article
id doaj.art-9c18515d4c5a47d69f520c4e4d418e15
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-14T05:41:23Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-9c18515d4c5a47d69f520c4e4d418e152022-12-22T02:09:26ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-019110.1371/annotation/7a99f22f-8273-43c0-b78f-8675ee409bf6Correction: Cytokine Receptor-Like Factor 1 () Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway.Brendan D. LooyengaJames ResauJeffrey P. MacKeiganhttp://europepmc.org/articles/PMC3882296
spellingShingle Brendan D. Looyenga
James Resau
Jeffrey P. MacKeigan
Correction: Cytokine Receptor-Like Factor 1 () Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway.
PLoS ONE
title Correction: Cytokine Receptor-Like Factor 1 () Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway.
title_full Correction: Cytokine Receptor-Like Factor 1 () Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway.
title_fullStr Correction: Cytokine Receptor-Like Factor 1 () Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway.
title_full_unstemmed Correction: Cytokine Receptor-Like Factor 1 () Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway.
title_short Correction: Cytokine Receptor-Like Factor 1 () Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway.
title_sort correction cytokine receptor like factor 1 protects against 6 hydroxydopamine toxicity independent of the gp130 jak signaling pathway
url http://europepmc.org/articles/PMC3882296
work_keys_str_mv AT brendandlooyenga correctioncytokinereceptorlikefactor1protectsagainst6hydroxydopaminetoxicityindependentofthegp130jaksignalingpathway
AT jamesresau correctioncytokinereceptorlikefactor1protectsagainst6hydroxydopaminetoxicityindependentofthegp130jaksignalingpathway
AT jeffreypmackeigan correctioncytokinereceptorlikefactor1protectsagainst6hydroxydopaminetoxicityindependentofthegp130jaksignalingpathway